Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use
Self-assembling nanoparticles (SANPs) promise an effective delivery of bisphosphonates or microRNAs in the treatment of glioblastoma (GBM) and are obtained through the sequential mixing of four components immediately before use. The self-assembling approach facilitates technology transfer, but the c...
Main Authors: | Abate, M. (Author), Biondi, M. (Author), Campani, V. (Author), Caraglia, M. (Author), De Rosa, G. (Author), Leonetti, C. (Author), Nele, V. (Author), Porru, M. (Author), Scotti, L. (Author), Zappavigna, S. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Collapsing Focal Segmental Glomerulosclerosis Resulting from a Single Dose of Zoledronate
by: Javier A. Neyra, et al.
Published: (2014-10-01) -
The anti-tumour effects of zoledronic acid
by: Jamal Zekri, et al.
Published: (2014-03-01) -
Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01) -
Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01) -
Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug Resistance
by: Simona Giarra, et al.
Published: (2018-10-01)